| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/1996 | EP0690852A1 Method for purifying taxoids |
| 01/10/1996 | EP0690850A1 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists |
| 01/10/1996 | EP0690849A1 Heterocycle-containing amidine derivatives, their preparation and use |
| 01/10/1996 | EP0690847A1 Heterocyclic compounds as platelet aggregation inhibitors |
| 01/10/1996 | EP0690845A1 Piperazine derivatives as 5-ht1a ligands |
| 01/10/1996 | EP0690843A1 Indoletetralins having dopaminergic activity |
| 01/10/1996 | EP0690842A1 4-arylisoindole analgesics |
| 01/10/1996 | EP0690841A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 01/10/1996 | EP0690840A1 Novel distamycin analogues |
| 01/10/1996 | EP0690726A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 01/10/1996 | EP0690724A1 Chlamydia vaccine and process |
| 01/10/1996 | EP0690719A1 Dry mix formulation for bisphosphonic acids |
| 01/10/1996 | EP0690718A1 Peritoneal dialysis solutions containing maltodextrins and amino acids |
| 01/10/1996 | EP0690717A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 01/10/1996 | EP0690716A1 OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH |
| 01/10/1996 | EP0690715A1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| 01/10/1996 | EP0690714A1 3-(7-oxo-1-aza-4-oxabicyclo 3.2.0]hept-3-yl) alanine derivative as antitumor agent |
| 01/10/1996 | EP0690713A1 Substituted alicyclic amine-containing macrocyclic immunomodulators |
| 01/10/1996 | EP0690712A1 Taxanes having a pyridyl substituted side-chain |
| 01/10/1996 | EP0690711A1 Taxanes having an amino substituted side-chain |
| 01/10/1996 | EP0690710A1 Use of cis-9-heptadecenoic acid for treating psoriasis, allergies and autoimmune diseases |
| 01/10/1996 | EP0690673A1 Systemic gene treatment of connective tissue diseases |
| 01/10/1996 | EP0690671A1 Method and apparatus for encapsulation of biologically-active substances in cells |
| 01/10/1996 | EP0671953A4 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide. |
| 01/10/1996 | EP0639078A4 Method of treating eye disorders with silicone/fluorosilicone copolymer oil. |
| 01/10/1996 | EP0613470B1 Novel 4-cinnolinone derivatives, their preparation and application in therapy |
| 01/10/1996 | EP0605578B1 Pressurised aerosol compositions |
| 01/10/1996 | EP0600949B1 New 3,5-di-tert.butyl-4-hydroxyphenyl derivatives, methods of preparing them and drugs containing them |
| 01/10/1996 | EP0599850B1 Composition and method for treating cystic fibrosis |
| 01/10/1996 | EP0591255B1 Tetrahydrobenzazepine derivatives which inhibit lipoxygenase |
| 01/10/1996 | EP0558570B1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/10/1996 | EP0556329B1 Substituted piperazines as central nervous system agents |
| 01/10/1996 | EP0543018B1 Antidiabetic agent |
| 01/10/1996 | EP0495879B1 Compositions and methods for weight reduction |
| 01/10/1996 | EP0482081B1 Antiviral composition |
| 01/10/1996 | EP0394429B1 Preparation for transdermal application containing gestodene |
| 01/10/1996 | CN1114824A 1 alpha, 24-(OH)2-vitamin D3 emulsion composition |
| 01/10/1996 | CN1114652A 8-amino-pyrido(1,2,3-D,E)(1,3,4) benzoxadiazine derivatives |
| 01/10/1996 | CN1114651A 3-indolylpiperidine |
| 01/10/1996 | CN1114650A MDR reversal agents |
| 01/10/1996 | CN1114648A Novel mono- and bicyclic DNA gyrase inhibitors |
| 01/10/1996 | CN1114644A Novel benzylaminoethoxybenzene derivatives, production thereof and use thereof |
| 01/10/1996 | CN1114587A EVA-based transdermal matrix system for the administration of an oestrogen and/or progestogen |
| 01/10/1996 | CN1114578A Oral medicine for curing seborrheic baldness |
| 01/10/1996 | CN1114564A New medicine for curing vascular system disease |
| 01/10/1996 | CN1114563A Anti-AIDS-virus drug composition |
| 01/10/1996 | CN1114559A Composition and application against senile plaque formed on skin and/or slow death |
| 01/10/1996 | CN1030659C Derivatives of 10, 11, 12, 13-tetrahydrodesmycosin, processes for preparation, and use thereof in pharmaceuticals |
| 01/10/1996 | CN1030658C Octadecyl (2-(N-methyl-priperidino)-ethyl)-phosphate and process for its preparation |
| 01/10/1996 | CN1030657C Method for preparing autibacterial compounds |
| 01/09/1996 | US5482975 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents |
| 01/09/1996 | US5482973 Suppository preparation |
| 01/09/1996 | US5482970 Transdermal antiandrogenic compositions and modulated process |
| 01/09/1996 | US5482969 Certain N(4-benzoyl-2-phenyl)-3- trifluoro-2-hydroxy-propanamide derivatives |
| 01/09/1996 | US5482966 Oxime derivatives |
| 01/09/1996 | US5482965 Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers for physiological active agents |
| 01/09/1996 | US5482963 Pharmaceutical agents useful as leukotriene antagonists |
| 01/09/1996 | US5482960 Nonpeptide endothelin antagonists |
| 01/09/1996 | US5482959 Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds |
| 01/09/1996 | US5482958 Method for treating endometriosis |
| 01/09/1996 | US5482957 Azole derivatives, process for their preparation and their use |
| 01/09/1996 | US5482956 Method of treating parastic protozoa with substituted benzimidazoles |
| 01/09/1996 | US5482954 Antitumor agents, interruption of signalling mechanism required for survival of malignant cells |
| 01/09/1996 | US5482953 2,4-and 2,5-bistetrazolylpyridines and the use thereof as pharmaceuticals |
| 01/09/1996 | US5482950 Methods for lowering serum cholesterol |
| 01/09/1996 | US5482949 Inhibiting bone loss, lowering cholesterol levels, and treating estrogen dependent mammary or uterine carcinoma |
| 01/09/1996 | US5482948 Pyridyl derivatives and pharmaceutical compositions comprising these compounds |
| 01/09/1996 | US5482947 Retroviral protease inhibitors |
| 01/09/1996 | US5482945 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 01/09/1996 | US5482944 Administering to alleviate tumor necrosis factor-related disorders |
| 01/09/1996 | US5482943 (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl-alkyl-(2,9-disubstituted-4H-pyrido[1,2-a]pyrimidin-4-one) derivatives |
| 01/09/1996 | US5482942 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 01/09/1996 | US5482941 Quinazolinone antianginal agents |
| 01/09/1996 | US5482938 Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
| 01/09/1996 | US5482936 Imidazo[4,5-C]quinoline amines |
| 01/09/1996 | US5482935 Anti-atherosclerotic use of 17 alpha-dihydroequilin |
| 01/09/1996 | US5482934 Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
| 01/09/1996 | US5482925 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
| 01/09/1996 | US5482828 Synthetic media compositions and methods for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen |
| 01/09/1996 | US5482716 Medicaments |
| 01/09/1996 | US5482712 Galenic composition |
| 01/09/1996 | US5482053 Condom lubricants containing zinc as an anti-viral agent |
| 01/09/1996 | CA2153432A1 Substituted 1-(7-chloroquinolin-4-yl) pyrazole-3-carboxamide n-oxide derivatives, method of preparing them and the pharmaceutical compositions in which they are present |
| 01/09/1996 | CA2106679C Novel platinum (ii) complex and processes for preparing the same |
| 01/09/1996 | CA2095138C Semduramicin premix |
| 01/09/1996 | CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use |
| 01/09/1996 | CA2022081C Treatment of hyperlipidemia with 15-keto-prostaglandin compounds |
| 01/09/1996 | CA2014659C Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process |
| 01/09/1996 | CA2013895C Substituted 1-¬3-(heteroarylmethoxy)phenyl|alkanols and related compounds in the treatment of asthma, arthritis and related diseases |
| 01/09/1996 | CA1337909C Non-peptide renin inhibitors |
| 01/09/1996 | CA1337907C Antifungal antibiotic bu-3608 complex |
| 01/09/1996 | CA1337897C Medicated cleansing pads |
| 01/08/1996 | CA2153294A1 1,3-dihydro-2h-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2(3h)-one amino derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 01/08/1996 | CA2127573A1 Vasotonic treatment for migraines |
| 01/07/1996 | CA2153213A1 Methods of inhibiting bone loss |
| 01/06/1996 | CA2153270A1 Hiv protease inhibitor combinations |
| 01/06/1996 | CA2133514A1 Restorative neuropharmacological agent for motor and speech disturbance |
| 01/04/1996 | WO1996000396A1 Improved methods for the determination and adjustment of prolactin daily rhythms |
| 01/04/1996 | WO1996000235A1 Sterol derivatives used for regulation of meiosis |
| 01/04/1996 | WO1996000232A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF |